A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study

Autor: Salvatore Minisola, Antonio P Vargas, Giulia Letizia Mauro, Fernando Bonet Madurga, Giovanni Adami, Dennis M Black, Nawab Qizilbash, Josep Blanch‐Rubió

Publikováno v: JBMR Plus, Vol 5, Iss 7, Pp n/a-n/a (2021)

ABSTRACT Upper gastrointestinal (GI) side effects are a main reason for discontinuing bisphosphonate treatment, an important therapeutic option for osteoporosis patients. Consequently, the development of novel formulations with improved tolerability

Externí odkaz: https://doaj.org/article/8bf5fc80eff84a7a91cd56a41e55333c

Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions

Autor: Manuel Ciria-Recasens, Rafael de la Torre, Jone Llorente-Onaindia, Laura Tío, Natalia Soldevila-Domenech, Josep Blanch-Rubió, Alba Gurt, Jordi Monfort, Rafael Maldonado, Luciano Polino

Publikováno v: Aging (Albany NY)

Coronavirus disease 19 (COVID-19) is currently a global pandemic that affects patients with other pathologies. Here, we investigated the influence of treatments for osteoporosis and other non-inflammatory rheumatic conditions, such as osteoarthritis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4880fb2733858b55078d3eedb4525064
https://pubmed.ncbi.nlm.nih.gov/33080571

Screening for the presence of FMR1 premutation alleles in women with fibromyalgia

Autor: Javier Vidal, Irene Madrigal, Elisa Docampo, Montserrat Milà, Laia Rodriguez-Revenga, Jordi Carbonell, Dei M. Elurbe, Josep Blanch-Rubió, Xavier Estivill, Antonio Collado

Publikováno v: Gene. 512:305-308

Fibromyalgia is a chronic condition characterized by widespread pain, fatigue, non-restorative sleep and cognitive difficulties that affects 2–4% of the general population. Recently a possible relationship between the FMR1 premutation and fibromyal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60d3beca2351a6b2d66b67ae5d4401bc
https://doi.org/10.1016/j.gene.2012.10.016

Calcium Citrate and Vitamin D in the Treatment of Osteoporosis

Autor: Adolfo Díez Pérez, Manuel Diaz Curiel, Josep Blanch Rubió, José Manuel Quesada Gómez

Publikováno v: Clinical Drug Investigation. 31:285-298

The combination of calcium with vitamin D (vitamin D(3) [colecalciferol]) forms the basis of preventive and therapeutic regimens for osteoporosis. A number of studies have suggested that the combination of calcium and vitamin D is effective when admi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99ad30ceb68d8ca36ce3c1bb46403d85
https://doi.org/10.1007/bf03256927

Efficacy of ossein-hydroxyapatite complex compared with calcium carbonate to prevent bone loss

Autor: Josep Blanch-Rubió, L. Pérez-Edo, Maria Jesús Cancelo-Hidalgo, Javier Haya-Palazuelos, Santiago Palacios, Jordi Carbonell-Abelló, Manel Ciria-Recasens, Camil Castelo-Branco, Maria José Martinez-Zapata, José Manasanch

Publikováno v: MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Objective: There is increasing evidence to suggest that ossein-hydroxyapatite complex (OHC) is more effective than calcium supplements in maintaining bone mass. The aim of this meta-analysis was to determine whether OHC has a different clinical effec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2562c4fc41e133e9f6b9a4f097291b6
https://doi.org/10.1097/gme.0b013e3181a1824e